NYSE: HUM | Healthcare / Healthcare Plans / USA |
418.65 | +5.44 | +1.32% | Vol 491.25K | 1Y Perf 20.24% |
Apr 13th, 2021 15:46 DELAYED |
BID | 418.58 | ASK | 418.73 | ||
Open | 411.55 | Previous Close | 413.21 | ||
Pre-Market | 413.21 | After-Market | - | ||
- -% | - - |
Target Price | 468.38 | Analyst Rating | Strong Buy 1.43 | |
Potential % | 11.87 | Finscreener Ranking | ★★★★ 53.99 | |
Insiders Trans % 3/6/12 mo. | -60/-89/-90 | Value Ranking | ★★★+ 53.09 | |
Insiders Value % 3/6/12 mo. | -98/-100/-100 | Growth Ranking | ★★★★+ 65.65 | |
Insiders Shares Cnt. % 3/6/12 mo. | -98/-100/-100 | Income Ranking | ★★ 40.32 | |
Market Cap | 54.01B | Earnings Rating | Strong Buy | |
Price Range Ratio 52W % | 56.80 | Earnings Date | 28th Apr 2021 |
Today's Price Range 411.55420.00 | 52W Range 344.95474.70 | 5 Year PE Ratio Range 10.4065.20 |
Summary:
Buy
Technical Indicators: | Neutral |
Moving Averages: | Strong Buy |
Performance | |||
---|---|---|---|
1 Week | 1.44% | ||
1 Month | 1.64% | ||
3 Months | -0.68% | ||
6 Months | -4.53% | ||
1 Year | 20.24% | ||
3 Years | 43.67% | ||
5 Years | 143.52% | ||
10 Years | 513.45% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 19.16 | |||
ROE last 12 Months | 25.10 | |||
ROA (5Y Avg) | 6.79 | |||
ROA last 12 Months | 10.11 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | - | |||
Return on invested Capital Q | - | |||
Return on invested Capital Y | - | |||
Assets Turnover | 1.70 | |||
Receivables Turnover | - |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
16.10 | ||||
3.83 | ||||
0.92 | ||||
9.60 | ||||
12.70 | ||||
42.39 | ||||
5.87 | ||||
106.41 | ||||
54.83B | ||||
Forward PE | 17.03 | |||
PEG | 1.33 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
0.31 | ||||
0.51 | ||||
17.50 | ||||
Leverage Ratio | 2.60 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
6.30 | ||||
- | ||||
3.40 | ||||
5.06 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
58.22B | ||||
451.27 | ||||
12.59 | ||||
6.94 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.68 | ||||
2.80 | ||||
9.80 | ||||
21.18 | ||||
Payout ratio | 7.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q04 2020 | -2.35 | -2.30 | 2.13 |
Q03 2020 | 2.86 | 3.08 | 7.69 |
Q02 2020 | 10.34 | 12.56 | 21.47 |
Q01 2020 | 4.84 | 5.40 | 11.57 |
Q04 2019 | 2.20 | 2.28 | 3.64 |
Q03 2019 | 4.58 | 5.03 | 9.83 |
Q02 2019 | 5.24 | 6.05 | 15.46 |
Q01 2019 | 4.30 | 4.48 | 4.19 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
3/2021 QR | 7.21 | 18.00 | Positive |
6/2021 QR | 7.23 | 4.03 | Positive |
12/2021 FY | 21.61 | -0.60 | Negative |
12/2022 FY | 24.52 | -0.85 | Negative |
Next Report Date | 28th Apr 2021 |
Estimated EPS Next Report | 7.21 |
Estimates Count | 8 |
EPS Growth Next 5 Years % | 12.10 |
Volume Overview | |
---|---|
Volume | 491.25K |
Shares Outstanding | 129.01M |
Trades Count | 12.24K |
Dollar Volume | 393.03M |
Avg. Volume | 1.08M |
Avg. Weekly Volume | 691.26K |
Avg. Monthly Volume | 901.06K |
Avg. Quarterly Volume | 1.07M |
Humana Inc. (NYSE: HUM) stock closed at 413.21 per share at the end of the most recent trading day (a -1.08% change compared to the prior day closing price) with a volume of 790.04K shares and market capitalization of 54.01B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 48700 people. Humana Inc. CEO is Bruce D. Broussard.
The one-year performance of Humana Inc. stock is 20.24%, while year-to-date (YTD) performance is 0.72%. HUM stock has a five-year performance of 143.52%. Its 52-week range is between 344.95 and 474.7, which gives HUM stock a 52-week price range ratio of 56.80%
Humana Inc. currently has a PE ratio of 16.10, a price-to-book (PB) ratio of 3.83, a price-to-sale (PS) ratio of 0.92, a price to cashflow ratio of 9.60, a PEG ratio of 2.32, a ROA of 10.11%, a ROC of -% and a ROE of 25.10%. The company’s profit margin is 5.06%, its EBITDA margin is -%, and its revenue ttm is $58.22 Billion , which makes it $451.27 revenue per share.
Of the last four earnings reports from Humana Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $7.21 for the next earnings report. Humana Inc.’s next earnings report date is 28th Apr 2021.
The consensus rating of Wall Street analysts for Humana Inc. is Strong Buy (1.43), with a target price of $468.38, which is +11.87% compared to the current price. The earnings rating for Humana Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Humana Inc. has a dividend yield of 0.68% with a dividend per share of $2.80 and a payout ratio of 7.00%.
Humana Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 8.66, ATR14 : 11.46, CCI20 : 42.73, Chaikin Money Flow : -0.01, MACD : 3.19, Money Flow Index : 60.65, ROC : -0.35, RSI : 58.48, STOCH (14,3) : 38.67, STOCH RSI : 0.69, UO : 45.46, Williams %R : -61.33), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Humana Inc. in the last 12-months were: Brian A. Kane (Option Excercise at a value of $6 521 363), Brian A. Kane (Sold 49 153 shares of value $21 884 216 ), Bruce D. Broussard (Option Excercise at a value of $15 649 946), Bruce D. Broussard (Sold 92 148 shares of value $39 561 859 ), Christopher H. Hunter (Option Excercise at a value of $3 197 087), Christopher H. Hunter (Sold 16 904 shares of value $7 502 650 ), Cynthia H. Zipperle (Option Excercise at a value of $0), Cynthia H. Zipperle (Sold 1 000 shares of value $443 582 ), David A. Jones (Sold 5 000 shares of value $1 963 800 ), Heather M. Carroll Cox (Option Excercise at a value of $0), John W. Garratt (Option Excercise at a value of $0), Jorge S. Mesquita (Buy at a value of $151 263), Joseph C. Ventura (Option Excercise at a value of $0), Karen W. Katz (Option Excercise at a value of $0), Marissa T. Peterson (Sold 2 492 shares of value $996 526 ), Samir Deshpande (Option Excercise at a value of $0), Susan M. Diamond (Option Excercise at a value of $0), Susan M. Diamond (Sold 1 580 shares of value $594 115 ), Timothy Alan Wheatley (Option Excercise at a value of $2 965 380), Timothy Alan Wheatley (Sold 15 259 shares of value $6 818 540 ), Timothy S. Huval (Option Excercise at a value of $1 319 361), Timothy S. Huval (Sold 8 685 shares of value $3 621 577 ), Vishal Agrawal (Option Excercise at a value of $0), Wayne A.I. Frederick (Option Excercise at a value of $0), William H Shrank (Option Excercise at a value of $0), William Kevin Fleming (Option Excercise at a value of $2 772 041), William Kevin Fleming (Sold 16 611 shares of value $7 133 214 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services and pharmacy benefit management.
CEO: Bruce D. Broussard
Telephone: +1 502 580-1000
Address: 500 West Main Street, Louisville 40202, KY, US
Number of employees: 48 700
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE BZX (BATS) real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2021. All market data is provided by Barchart Solutions. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.